Calypxo Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Calypxo Pain Relief
Generic name
METHYL SALICYLATE, MENTHOL
Manufacturer
Advanced Rx of Tennessee, LLC
Product type
HUMAN OTC DRUG
SPL set ID
0b7736df-c7e0-7d00-e063-6294a90aa57e
SPL ID
2a994ea2-2575-6513-e063-6394a90a7bc2
Version
2
Effective date
2024-12-31
Source export date
2026-09-28
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:38:13
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning For external use only. Avoid contact with eyes and mucous membranes. Do not bandage tightly or cover treated areas. Do not use with heating pad. Do not apply to open wounds or damages skin. A mild burning sensation may occur. If severe burning sensation occurs, discontinue use immediately. If symptoms persist for more than seven days, discontinue use and consult physician. Keep out of reach of children. If swallowed, consult physician. If pregnant or breast feeding, contact physician prior to use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.